Do oxidatively modified proteins cause ALS?

Free Radical Biology and Medicine

Volumn 33, Issue 10, 2002, Pages 1314-1320

  Valentine, Joan Selverstone ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyotrophic lateral sclerosis; Copper; Free radical; Neurodegenerative disease; Protein aggregation; Protein oxidation; Superoxide dismutase; Zinc

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MUTANT PROTEIN; SUPEROXIDE DISMUTASE; COPPER; FREE RADICAL; OXYGEN; ZINC;

AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; FAMILIAL DISEASE; HUMAN; MUTATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; PROTEIN MODIFICATION; REVIEW; ANIMAL; ENZYMOLOGY; METABOLISM;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; COPPER; FREE RADICALS; HUMANS; MUTATION; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; OXYGEN; SUPEROXIDE DISMUTASE; ZINC;

EID: 0037111503     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01080-8     Document Type: Article

References (59)

1. Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 344:2001;1688-1700.
2. Hayward C., Brock D.J., Minns R.A., Swingler R.J. Homozygosity for Asn86Ser mutation in the CuZn superoxide dismutase gene produces a severe clinical phenotype in a juvenile onset case of familial amyotrophic lateral sclerosis. J. Med. Genet. 35:1998;174.
3. Andersen P.M., Nilsson P., Ala-Hurula V., Keranen M.L., Tarvainen I., Haltia T., Nilsson L., Binzer M., Forsgren L., Marklund S.L. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn superoxide dismutase. Nat. Genet. 10:1995;61-66.
4. Dal Canto M.C., Gurney M.E. A low expressor line of transgenic mice carrying a mutant human CuZn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.). 93:1997;537-550.
5. Dal Canto M.C., Gurney M.E. Neuropathological changes in two lines of mice carrying a transgene for mutant human CuZnSOD, and in mice overexpressing wild-type human SOD a model of familial amyotrophic lateral sclerosis (FALS) . Brain Res. 676:1995;25-40.
6. Gurney M.E. Transgenic animal models of familial amyotrophic lateral sclerosis. J. Neurol. 244:(Suppl. 2):1997;S15-S20.
7. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 18:1997;327-338.
8. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., Wilcox H.M., Flood D.G., Beal M.F., Brown R.H. Jr, Scott R.W., Snider W.D. Motor neurons in CuZn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13:1996;43-47.
9. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., Rahmani Z., Krizus A., Mckennayasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Vandenbergh R., Hung W.Y., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericakvance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., Brown R.H. Jr. Mutations in CuZn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
10. Goto J.J., Zhu H., Sanchez R.J., Nersissian A., Gralla E.B., Valentine J.S., Cabelli D.E. Loss of in vitro metal ion binding specificity in mutant copper-zinc superoxide dismutases associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 275:2000;1007-1014.
11. Hart P.J., Liu H., Pellegrini M., Nersissian A.M., Gralla E.B., Valentine J.S., Eisenberg D. Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis. Protein Sci. 7:1998;545-555.
12. Goto J.J., Gralla E.B., Valentine J.S., Cabelli D.E. Reactions of hydrogen peroxide with familial amyotrophic lateral sclerosis mutant human copper-zinc superoxide dismutases studied by pulse radiolysis. J. Biol. Chem. 273:1998;30104-30109.
13. Hayward L.J., Rodriguez J.A., Kim J.W., Tiwari A., Goto J.J., Cabelli D.E., Valentine J.S., Brown R.H. Jr. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 277:2002;15923-15931.
14. Rodriguez J.A., Valentine J.S., Eggers D.K., Roe J.A., Tiwari A., Brown R.H. Jr, Hayward L.J. Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper-zinc superoxide dismutase. J. Biol. Chem. 277:2002;15932-15937.
15. Liu H., Zhu H., Eggers D.K., Nersissian A.M., Faull K.F., Goto J.J., Ai J., Sanders-Loehr J., Gralla E.B., Valentine J.S. Copper(2+) binding to the surface residue cysteine 111 of His46Arg human copper-zinc superoxide dismutase, a familial amyotrophic lateral sclerosis mutant. Biochemistry. 39:2000;8125-8132.
16. Kaytor M.D., Warren S.T. Aberrant protein deposition and neurological disease. J. Biol. Chem. 274:1999;37507-37510.
17. Julien J.P. Amyotrophic lateral sclerosis unfolding the toxicity of the misfolded . Cell. 104:2001;581-591.
18. Watanabe M., Dykes-Hoberg M., Culotta V.C., Price D.L., Wong P.C., Rothstein J.D. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 8:2001;933-941.
19. Koide T., Igarashi S., Kikugawa K., Nakano R., Inuzuka T., Yamada M., Takahashi H., Tsuji S. Formation of granular cytoplasmic aggregates in COS7 cells expressing mutant CuZn superoxide dismutase associated with familial amyotrophic lateral sclerosis. Neurosci. Lett. 257:1998;29-32.
20. Durham H.D., Roy J., Dong L., Figlewicz D.A. Aggregation of mutant CuZn superoxide dismutase proteins in a culture model of ALS. J. Neuropathol. Exp. Neurol. 56:1997;523-530.
21. Shibata N., Asayama K., Hirano A., Kobayashi M. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev. Neurosci. 18:1996;492-498.
22. Shibata N., Hirano A., Kobayashi M., Sasaki S., Kato T., Matsumoto S., Shiozawa Z., Komori T., Ikemoto A., Umahara T., Asayama K. CuZn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci. Lett. 179:1994;149-152.
23. Matsumoto S., Kusaka H., Ito H., Shibata N., Asayama T., Imai T. Sporadic amyotrophic lateral sclerosis with dementia and CuZn superoxide dismutase-positive Lewy body-like inclusions. Clin. Neuropathol. 15:1996;41-46.
24. Johnston J.A., Dalton M.J., Gurney M.E., Kopito R.R. Formation of high molecular weight complexes of mutant CuZn superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 97:2000;12571-12576.
25. Stieber A., Gonatas J.O., Gonatas N.K. Aggregation of ubiquitin and a mutant ALS-linked SOD1 protein correlate with disease progression and fragmentation of the Golgi apparatus. J. Neurol. Sci. 173:2000;53-62.
26. Stieber A., Gonatas J.O., Collard J., Meier J., Julien J., Schweitzer P., Gonatas N.K. The neuronal Golgi apparatus is fragmented in transgenic mice expressing a mutant human SOD1, but not in mice expressing the human NF-H gene. J. Neurol. Sci. 173:2000;63-72.
27. Stieber A., Gonatas J.O., Gonatas N.K. Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1(G93A) mutation of familial amyotrophic lateral sclerosis. J. Neurol. Sci. 177:2000;114-123.
28. Mourelatos Z., Gonatas N.K., Stieber A., Gurney M.E., Dal Canto M.C. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant CuZn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc. Natl. Acad. Sci. USA. 93:1996;5472-5477.
29. Kato S., Takikawa M., Nakashima K., Hirano A., Cleveland D.W., Kusaka H., Shibata N., Kato M., Nakano I., Ohama E. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations inclusions containing SOD1 in neurons and astrocytes . Amyotroph. Lateral. Scler. Other Motor Neuron Disord. 1:2000;163-184.
30. Kato S., Horiuchi S., Liu J., Cleveland D.W., Shibata N., Nakashima K., Nagai R., Hirano A., Takikawa M., Kato M., Nakano I., Ohama E. Advanced glycation end product-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with a G85R mutation. Acta Neuropathol. (Berl.). 100:2000;490-505.
31. Shibata N., Nagai R., Uchida K., Horiuchi S., Yamada S., Hirano A., Kawaguchi M., Yamamoto T., Sasaki S., Kobayashi M. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res. 917:2001;97-104.
32. Shibata N., Nagai R., Miyata S., Jono T., Horiuchi S., Hirano A., Kato S., Sasaki S., Asayama K., Kobayashi M. Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol. (Berl.). 100:2000;275-284.
33. Liu R., Althaus J.S., Ellerbrock B.R., Becker D.A., Gurney M.E. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann. Neurol. 44:1998;763-770.
34. Bogdanov M.B., Ramos L.E., Xu Z., Beal M.F. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J. Neurochem. 71:1998;1321-1324.
35. Lyons T.J., Liu H., Goto J.J., Nersissian A., Roe J.A., Graden J.A., Cafe C., Ellerby L.M., Bredesen D.E., Gralla E.B., Valentine J.S. Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc. Natl. Acad. Sci. USA. 93:1996;12240-12244.
36. Fujii J., Myint T., Seo H.G., Kayanoki Y., Ikeda Y., Taniguchi N. Characterization of wild-type and amyotrophic lateral sclerosis-related mutant CuZn superoxide dismutases overproduced in baculovirus-infected insect cells. J. Neurochem. 64:1995;1456-1461.
37. Yim M.B., Kang J.H., Yim H.S., Kwak H.S., Chock P.B., Stadtman E.R. A gain-of-function of an amyotrophic lateral sclerosis-associated CuZn superoxide dismutase mutant an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide . Proc. Natl. Acad. Sci. USA. 93:1996;5709-5714.
38. Okado-Matsumoto A., Myint T., Fujii J., Taniguchi N. Gain in functions of mutant CuZn superoxide dismutases as a causative factor in familial amyotrophic lateral sclerosis less reactive oxidant formation but high spontaneous aggregation and precipitation . Free Radic. Res. 33:2000;65-73.
39. Crow J.P., Sampson J.B., Zhuang Y., Thompson J.A., Beckman J.S. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69:1997;1936-1944.
40. Estevez A.G., Crow J.P., Sampson J.B., Reiter C., Zhuang Y., Richardson G.J., Tarpey M.M., Barbeito L., Beckman J.S. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science. 286:1999;2498-2500.
41. Beckman J.S., Estvez A.G., Crow J.P., Barbeito L. Superoxide dismutase and the death of motoneurons in ALS. TINS. 24:2001;S15-S20.
42. Andrus P.K., Fleck T.J., Gurney M.E., Hall E.D. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 71:1998;2041-2048.
43. Beckman J.S., Carson M., Smith C.D., Koppenol W.H. ALS, SOD, and peroxynitrite. Nature. 364:1993;584.
44. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:1996;515-518.
45. Valentine, J. S. Reactions of copper-zinc superoxide dismutases with hydrogen peroxide. Possible involvement in familial amyotrophic lateral sclerosis. In: Sarkar, B., ed. Metals and Genetics. Proceedings of the Second International Symposium on Metals and Genetics. New York: Kluwer Academic; 1999:221-228.
46. Roe J.A., Wiedau-Pazos M., Moy V.N., Goto J.J., Gralla E.B., Valentine J.S. In vivo peroxidative activity of FALS-mutant human CuZnSODs expressed in yeast. Free Radic. Biol. Med. 32:2002;169-174.
47. Yim H.S., Kang J.H., Chock P.B., Stadtman E.R., Yim M.B. A familial amyotrophic lateral sclerosis-associated A4V CuZn superoxide dismutase mutant has a lower Km for hydrogen peroxide. Correlation between clinical severity and the Km value. J. Biol. Chem. 272:1997;8861-8863.
48. Zhang H., Joseph J., Felix C., Kalyanaraman B. Bicarbonate enhances the hydroxylation, nitration, and peroxidation reactions catalyzed by copper-zinc superoxide dismutase. Intermediacy of carbonate anion radical. J. Biol. Chem. 275:2000;14038-14045.
49. Sankarapandi S., Zweier J.L. Bicarbonate is required for the peroxidase function of CuZn superoxide dismutase at physiological pH. J. Biol. Chem. 274:1999;1226-1232.
50. 2. Proc. Natl. Acad. Sci. USA. 95:1998;6675-6680.
51. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 281:1998;1851-1854.
52. Cleveland D.W., Liu J. Oxidation versus aggregation how do SOD1 mutants cause ALS? Nat. Med. 6:2000;1320-1321.
53. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig deciphering selective motor neuron death in ALS . Nat. Rev. Neurosci. 2:2001;806-819.
54. Brown R.H. Jr. SOD1 aggregates in ALS cause, correlate, or consequence? Nat. Med. 4:1998;1362-1364.
55. Subramaniam J.R., Lyons W.E., Liu J., Bartnikas T.B., Rothstein J., Price D.L., Cleveland D.W., Gitlin J.D., Wong P.C. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5:2002;301-307.
56. Wong P.C., Waggoner D., Subramaniam J.R., Tessarollo L., Bartnikas T.B., Culotta V.C., Price D.L., Rothstein J., Gitlin J.D. Copper chaperone for superoxide dismutase is essential to activate mammalian CuZn superoxide dismutase. Proc. Natl. Acad. Sci. USA. 97:2000;2886-2891.
57. Orr H.T. A proposed mechanism of ALS fails the test in vivo. Nat. Neurosci. 5:2002;287-288.
58. Bredesen D.E., Ellerby L.M., Hart P.J., Wiedau-Pazos M., Valentine J.S. Do post-translational modifications of CuZnSOD lead to sporadic amyotrophic lateral sclerosis? Ann. Neurol. 42:1997;135-137.
59. Taylor J.P., Hardy J., Fischbeck K.H. Toxic proteins in neurodegenerative disease. Science. 296:2002;1991-1995.